Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine as Therapeutic Vaccine for COVID-19
NCT04369794Phase 4Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccine with Placebo (2 arms). Primary endpoints: Clinical evolution of COVID-19 at 45 days, SARS-CoV-2 elimination at 7 days and 1 more. Started Oct 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04369794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04369794.